Utilizing hiPSC-Derived Neurons and Cardiomyocytes For Drug Screening

Video   Oct 18, 2016

 

Patient specific induced pluripotent stem cells (iPSC) complement traditional cell-based assays used in drug discovery and could aid in the development of clinically useful compounds. They allow interrogation of differentiated features of human cells not reflected by immortalized lines, and importantly they carry disease-specific traits in complex genetic backgrounds that can impact disease phenotypes. Development of technology platforms to perform compound screens of iPSC with relatively high-throughput will be essential to realize their potential for disease modeling and drug discovery. Towards this goal, we have been working to develop a standardized battery of assays against which iPSC-derived neurons can be screened for specific phenotypes. We will discuss our screening results and development of patient cell specific and hiPSC based models for testing of drugs on disease relevant cell types.

 
 
 
 

Recommended Videos

PerkinElmer VICTOR Nivo Multimode Plate Reader - So Much Science So Little Bench Space

Video

The VICTOR Nivo system: The next big thing in plate readers is now the smallest.

WATCH NOW

How does a medicine get from the lab to patients?

Video

How is a new medicine for your disease approved by the European Medicines Agency?

WATCH NOW

LeNeo - Fusion Instrument

Video

LeNeo fusion instrument is an automatic and single position electrical instrument that prepares glass disks for XRF as well as solutions (borate and peroxide) for AA and ICP analysis.

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE